Your session is about to expire
← Back to Search
Work Rest Cycles for Heat Stress Disorders
N/A
Waitlist Available
Led By Glen P Kenny, PhD
Research Sponsored by University of Ottawa
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up period of work-rest allocations following initial stay time for morning day 2
Awards & highlights
No Placebo-Only Group
Summary
This trial will explore how work and rest times in hot environments affect the health and safety of workers, and how individual variation and next day effects should be considered.
Who is the study for?
This trial is for young (18-30 years) and older adults (50-69 years) who are generally active but not endurance-trained, do not smoke, and can understand English or French to give informed consent. It's designed to help workplaces manage the health and safety of workers in hot environments.
What is being tested?
The study tests how long people can safely work in heat before needing a break to avoid overheating. It will refine guidelines for initial stay times during moderate-intensity work in heat, considering individual variations and effects of rest periods like lunch breaks.
What are the potential side effects?
Since this trial involves simulated work in the heat, potential side effects may include symptoms related to heat stress such as increased core body temperature, fatigue, dehydration, dizziness or fainting.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ period of work-rest allocations following initial stay time for morning day 2
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~period of work-rest allocations following initial stay time for morning day 2
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Average core temperature
Initial stay time
Secondary study objectives
Average heart rate
Average skin temperature
Change in plasma volume
+12 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Younger adultsExperimental Treatment1 Intervention
Adults aged 18-30 years with no pre-existing health conditions
Group II: Older adultsExperimental Treatment1 Intervention
Adults aged 50-69 with no pre-existing health conditions
Find a Location
Who is running the clinical trial?
University of OttawaLead Sponsor
221 Previous Clinical Trials
269,589 Total Patients Enrolled
Glen P Kenny, PhDPrincipal InvestigatorUniversity of Ottawa
10 Previous Clinical Trials
237 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not taking medications that affect my body's ability to regulate temperature.I am either 18-30 years old or 50-69 years old.I speak English or French.
Research Study Groups:
This trial has the following groups:- Group 1: Younger adults
- Group 2: Older adults
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger